Overview
The Global AI In Remote Patient Monitoring Market size is expected to be worth around USD 24 Billion by 2033, from USD 2.3 Billion in 2023, growing at a CAGR of 26.6% during the forecast period from 2024 to 2033.
Artificial intelligence is transforming remote patient monitoring (RPM) by enabling healthcare providers to deliver continuous, data-driven care beyond traditional clinical settings. AI-powered RPM platforms integrate wearable devices, connected medical equipment, predictive analytics, and automated insights to monitor patient conditions, identify potential health risks, and support timely medical interventions. The technology is increasingly being used for managing chronic diseases such as diabetes, cardiovascular disorders, hypertension, and respiratory conditions.
Remote patient monitoring allows patients to collect health information, including blood pressure, glucose levels, weight, heart rate, and oxygen saturation, through connected devices that transmit data to healthcare professionals. According to the Centers for Medicare & Medicaid Services (CMS), RPM uses connected medical devices to automatically send patient health data to providers, helping support treatment decisions and ongoing condition management.
The rising burden of chronic diseases is encouraging healthcare systems to adopt AI-enabled monitoring solutions for preventive and personalized care. The Centers for Disease Control and Prevention (CDC) reports that 6 in 10 adults in the United States live with at least one chronic disease, highlighting the need for improved long-term disease management strategies.
AI technologies enhance RPM by analyzing large volumes of patient-generated data, detecting abnormal patterns, and assisting clinicians with early risk identification. Additionally, advancements in wearable sensors, cloud-based healthcare platforms, and digital health infrastructure are supporting the expansion of intelligent remote monitoring solutions worldwide.
Key Takeaways
- The Global AI In Remote Patient Monitoring Market size is expected to be worth around USD 24 Billion by 2033.
- The Market is growing at a CAGR of 26.6% during the forecast period from 2024 to 2033.
- Based on monitoring devices, the wearable segment dominated the AI in remote patient monitoring market in 2023, accounting for a significant 61.2% market share due to the increasing adoption of smart wearable technologies for continuous health tracking.
- The software segment captured a leading 75.3% market share, driven by the growing use of AI-based software solutions for disease diagnosis, data analysis, and personalized treatment planning.
- By technology, the machine learning segment emerged as the leading contributor in 2023, holding a substantial 53.9% market share due to its ability to analyze complex healthcare data and support predictive insights.
- Based on application, the chronic disease management segment led the AI-powered remote patient monitoring market with a 55.2% market share, supported by the rising need for continuous monitoring and improved management of long-term health conditions.
- Regionally, North America dominated the AI in remote patient monitoring market in 2023, accounting for a notable 29.9% market share due to the strong adoption of digital health technologies and advanced healthcare infrastructure.
Statistical Information
- Medicare payments for Remote Patient Monitoring (RPM) exceeded USD 500 million in 2024, reflecting the rapid expansion of RPM services across the U.S. healthcare system.
- About 43% of Medicare beneficiaries receiving RPM between 2019 and 2022 did not receive all three required RPM service components, highlighting opportunities to improve implementation and care quality.
- CMS requires connected RPM devices to transmit at least 2 patient readings every 30 days for reimbursement, ensuring providers receive sufficient health data for clinical decision-making.
- Medicare requires RPM physiologic monitoring data to be collected for at least 16 days within a 30-day period to qualify for reimbursement under standard billing requirements.
- A U.S. healthcare survey found that 96% of respondents owned a smartphone, demonstrating a strong digital foundation for AI-enabled remote patient monitoring adoption.
- The same survey reported that only 30% of respondents had used remote patient monitoring services, indicating substantial growth potential for AI-powered RPM solutions.
- Wearable health devices were used by only 14% of respondents in the surveyed U.S. population, suggesting considerable opportunity for expanding AI-enabled wearable monitoring.
- According to HHS, RPM supports monitoring of at least 8 major care areas, including diabetes, heart disease, hypertension, lung disease, pregnancy, cancer care, nutrition, and post-surgical recovery, demonstrating its broad clinical applicability.
Regional Analysis
North America dominated the AI in Remote Patient Monitoring (RPM) market in 2023, accounting for 29.9% of the global market share. The region’s leadership is supported by its advanced digital healthcare infrastructure, widespread adoption of telehealth services, and favorable reimbursement policies for remote monitoring technologies. The United States continues to drive regional growth through strong investments in artificial intelligence, connected medical devices, and digital health platforms.
According to the U.S. Department of Health and Human Services (HHS), RPM enables healthcare providers to monitor patients remotely using connected devices such as blood pressure monitors, glucose meters, pulse oximeters, and wearable sensors, improving chronic disease management and reducing unnecessary hospital visits.
The growing burden of chronic diseases is another major factor supporting market expansion. According to the CDC, 90% of the nation’s USD 5.3 trillion annual healthcare expenditure is spent on people living with chronic and mental health conditions. Additionally, more than 850,000 Americans died from heart disease or stroke in 2024, emphasizing the need for continuous monitoring and early intervention.
These healthcare challenges, combined with high digital adoption, strong AI innovation, and supportive government initiatives, continue to strengthen North America’s position as the leading regional market for AI-powered remote patient monitoring solutions.
Emerging Trends
- AI is becoming a core part of national healthcare strategies. In 2025, the U.S. Department of Health and Human Services (HHS) introduced a department-wide AI strategy to expand AI adoption across agencies including the FDA, CMS, CDC, and NIH, accelerating innovation in remote monitoring and digital healthcare.
- Wearable devices are generating richer health data for AI analysis. NIH research found that a single smartwatch can produce more than 250,000 health measurements per person per day, enabling AI systems to identify subtle physiological changes and detect potential illnesses much earlier than traditional monitoring methods.
- Telehealth infrastructure is strengthening RPM adoption. According to HHS, 95% of HRSA-funded health centers provided primary care through telehealth in 2024, creating a strong foundation for integrating AI-powered remote monitoring into routine healthcare delivery across urban and rural communities.
- Connected medical devices are becoming more sophisticated. Modern RPM solutions now combine AI with connected blood pressure monitors, glucose meters, pulse oximeters, smart scales, spirometers, sleep monitors, and wearable sensors to deliver continuous, real-time patient monitoring outside hospitals.
- Healthcare providers are focusing on AI governance alongside innovation. HHS reported significant expansion of AI initiatives across federal health agencies, emphasizing responsible AI deployment, cybersecurity, interoperability, and standardized governance to support safe and scalable digital health solutions.
Use Cases
- Chronic disease management remains the largest clinical application. AI-powered RPM continuously tracks blood pressure, glucose, oxygen saturation, and heart rate, enabling clinicians to adjust treatment plans remotely and reduce unnecessary in-person visits for long-term disease management.
- AI is improving early infection detection. NIH demonstrated that AI analyzing data from smartwatches worn by 40 adults over several months could identify early signs of infection by detecting subtle changes in heart rate before symptoms became more noticeable.
- Maternal healthcare is expanding through AI-enabled monitoring. Remote monitoring systems use connected blood pressure monitors and fetal heart monitors to help clinicians identify pregnancy-related complications earlier while allowing expectant mothers to remain at home between clinical visits.
- Cancer patients are increasingly monitored outside hospitals. AI-enabled RPM platforms collect information such as body weight, physical activity, and blood pressure to help oncology teams monitor treatment progress, identify health changes, and support personalized follow-up care remotely.
- Post-surgical recovery is becoming more data-driven. AI-supported RPM allows healthcare providers to monitor vital signs, weight, oxygen levels, and recovery trends after hospital discharge, enabling earlier intervention when abnormal health patterns are detected and reducing avoidable readmissions.
Frequently Asked Questions About AI in Remote Patient Monitoring
- How does AI improve Remote Patient Monitoring?
AI continuously reviews patient-generated health data, identifies abnormal patterns, and alerts healthcare providers when intervention may be needed. This reduces manual monitoring, supports personalized care, and improves clinical decision-making for patients with chronic and acute conditions. - What factors are driving the AI in Remote Patient Monitoring Market?
The market is expanding due to the increasing prevalence of chronic diseases, wider adoption of connected medical devices, supportive Medicare reimbursement policies, and growing telehealth use. Medicare has supported RPM services since 2018, encouraging healthcare providers to integrate remote monitoring into routine care. - Which healthcare settings benefit most from AI-powered RPM?
Hospitals, physician practices, outpatient clinics, and home healthcare providers widely use AI-powered RPM. The technology supports continuous monitoring of patients with diabetes, hypertension, heart disease, respiratory illnesses, cancer, pregnancy-related conditions, and post-surgical recovery while reducing unnecessary in-person visits. - What devices are commonly used in AI-based RPM?
AI-enabled RPM commonly uses connected blood pressure monitors, glucose meters, pulse oximeters, heart rate monitors, smart scales, spirometers, ECG devices, and wearable sensors. These devices automatically transmit patient data to healthcare providers for continuous analysis and treatment management. - What challenges does the AI in Remote Patient Monitoring Market face?
The market faces challenges related to data privacy, cybersecurity, interoperability, regulatory compliance, and responsible AI use. Healthcare organizations are also focused on ensuring secure handling of protected health information and maintaining transparency when AI supports clinical decision-making. - How is artificial intelligence changing the future of RPM?
Artificial intelligence is transforming RPM by enabling predictive analytics, automated risk detection, personalized treatment recommendations, and early identification of patient deterioration. AI also improves workflow efficiency by reducing manual data review and supporting proactive healthcare management. - What is the future outlook for the AI in Remote Patient Monitoring Market?
The market is expected to benefit from continued investments in digital health, expanding telehealth services, responsible AI implementation, and broader adoption of connected medical devices. Integration with electronic health records and cloud-based healthcare platforms is expected to further improve patient care and operational efficiency.
Conclusion
The global AI in remote patient monitoring market is poised for significant growth, driven by the rising burden of chronic diseases, increasing adoption of wearable devices, and advancements in artificial intelligence. AI-powered RPM solutions are enhancing continuous health monitoring, predictive analytics, early risk detection, and personalized treatment.
Supportive reimbursement policies, expanding telehealth infrastructure, and growing investments in digital healthcare are further accelerating market development. Although data privacy, cybersecurity, and interoperability remain key challenges, ongoing technological advancements are expected to improve system efficiency and clinical outcomes. Consequently, the market is projected to witness substantial expansion through 2033.
